Radiological and Immunohistochemical Characteristics of PitNETs in 79 Patients Undergoing Neurosurgery

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2025 Feb 26

PMID 40002261

Authors

Anna Krzentowska

Ryszard Czepko

Dariusz Adamek

Michal Filipowicz

Elzbieta Broniatowska

Filip Golkowski

Affiliations

Soon will be listed here.

Abstract

The human pituitary is a gland located within a small bony box, the sella turcica, under the base of the brain [...].

References

McDowell B, Wallace R, Carnahan R, Chrischilles E, Lynch C, Schlechte J . Demographic differences in incidence for pituitary adenoma. Pituitary. 2010; 14(1):23-30. PMC: 3652258. DOI: 10.1007/s11102-010-0253-4. View

Ezzat S, Asa S, Couldwell W, Barr C, Dodge W, Vance M . The prevalence of pituitary adenomas: a systematic review. Cancer. 2004; 101(3):613-9. DOI: 10.1002/cncr.20412. View

Pico A . Agressive pituitary tumours: a diagnostic and therapeutic challenge for multidisciplinary pituitary units. Endocrinol Diabetes Nutr (Engl Ed). 2020; 67(2):75-77. DOI: 10.1016/j.endinu.2020.01.001. View

Lu L, Wan X, Xu Y, Chen J, Shu K, Lei T . Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. Diagnostics (Basel). 2022; 12(4). PMC: 9024548. DOI: 10.3390/diagnostics12040977. View

Hardy J, VEZINA J . Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol. 1976; 15:261-73. View

Giraldi E, Neill S, Mendoza P, Saindane A, Oyesiku N, Ioachimescu A . Functioning Crooke Cell Adenomas: Case Series and Literature Review. World Neurosurg. 2021; 158:e754-e765. DOI: 10.1016/j.wneu.2021.11.049. View

Ostrom Q, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019; 21(Suppl 5):v1-v100. PMC: 6823730. DOI: 10.1093/neuonc/noz150. View

Nishioka H, Inoshita N, Sano T, Fukuhara N, Yamada S . Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas. Endocr Pathol. 2012; 23(3):151-6. DOI: 10.1007/s12022-012-9208-9. View

Ge C, Wang Q, Wang W, Cheng L, Wang Y, Huang L . [Pituitary Crooke cell neuroendocrine tumor of adrenocorticotropic hormone differentiation-specific transcription factor lineage: a clinicopathological analysis of six cases]. Zhonghua Bing Li Xue Za Zhi. 2024; 53(7):722-727. DOI: 10.3760/cma.j.cn112151-20231208-00397. View

10.

Lopes M . The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017; 134(4):521-535. DOI: 10.1007/s00401-017-1769-8. View

11.

Pinzone J, Katznelson L, Danila D, Pauler D, Miller C, Klibanski A . Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab. 2000; 85(9):3053-7. DOI: 10.1210/jcem.85.9.6798. View

12.

Chanson P, Maiter D . The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract Res Clin Endocrinol Metab. 2019; 33(2):101290. DOI: 10.1016/j.beem.2019.101290. View

13.

Fang Y, Pei Z, Chen H, Wang R, Feng M, Wei L . Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis. Pituitary. 2021; 24(3):457-464. DOI: 10.1007/s11102-020-01122-3. View

14.

Maiter D . Management of Dopamine Agonist-Resistant Prolactinoma. Neuroendocrinology. 2018; 109(1):42-50. DOI: 10.1159/000495775. View

15.

Zhang Y, Zhang B, Lv C, Zhang N, Xing K, Wang Z . Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma. Theranostics. 2023; 13(11):3744-3760. PMC: 10334835. DOI: 10.7150/thno.81407. View

16.

Webb K, Laurent J, Okonkwo D, Lopes M, Vance M, Laws Jr E . Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery. 2003; 53(5):1076-84. DOI: 10.1227/01.neu.0000088660.16904.f7. View

17.

Chacko G, Chacko A, Lombardero M, Mani S, Seshadri M, Kovacs K . Clinicopathologic correlates of giant pituitary adenomas. J Clin Neurosci. 2009; 16(5):660-5. DOI: 10.1016/j.jocn.2008.08.018. View

18.

Wang E, Qian Z, Yamada S, Rahman M, Inosita N, Kageji T . Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol. 2009; 20(4):209-20. DOI: 10.1007/s12022-009-9094-y. View

19.

Ben-Shlomo A, Cooper O . Silent corticotroph adenomas. Pituitary. 2018; 21(2):183-193. DOI: 10.1007/s11102-018-0864-8. View

20.

Scheithauer B, Gaffey T, Lloyd R, Sebo T, Kovacs K, Horvath E . Pathobiology of pituitary adenomas and carcinomas. Neurosurgery. 2006; 59(2):341-53. DOI: 10.1227/01.NEU.0000223437.51435.6E. View